These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18084833)
1. [Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis]. Kibrik BS; Chelnokova OG Probl Tuberk Bolezn Legk; 2007; (11):14-9. PubMed ID: 18084833 [TBL] [Abstract][Full Text] [Related]
2. [Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis]. Chelnokova OG; Kibrik BS Probl Tuberk Bolezn Legk; 2003; (9):12-4. PubMed ID: 14598518 [TBL] [Abstract][Full Text] [Related]
3. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis]. Kibrik BS; Zakharov AV Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450 [TBL] [Abstract][Full Text] [Related]
4. [Problems of epidemiology, diagnosis and treatment of caseous pneumonia]. Kibrik BS; Chelnokova GA Probl Tuberk; 2002; (9):18-22. PubMed ID: 12524982 [TBL] [Abstract][Full Text] [Related]
5. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis]. Pletnev GV; Krasnov DV Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961 [No Abstract] [Full Text] [Related]
6. [Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia]. Kibrik BS; Chelnokova OG Probl Tuberk Bolezn Legk; 2004; (12):25-9. PubMed ID: 15719662 [TBL] [Abstract][Full Text] [Related]
7. [Use of trental for correction of disorders in the system of hemostasys in patients with fibro-cavernous tuberculosis and chronic pulmonary heart]. Aliev RS; Agaev FF; Alieva LP Georgian Med News; 2012 Jan; (202):32-5. PubMed ID: 22392780 [TBL] [Abstract][Full Text] [Related]
8. [Some specific features of drug resistance of Mycobacteria tuberculosis in patients with acutely progressive destructive forms of pulmonary tuberculosis]. Kibrik BS; Chelnokova OG Probl Tuberk Bolezn Legk; 2003; (8):3-5. PubMed ID: 14524088 [TBL] [Abstract][Full Text] [Related]
9. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis]. Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532 [TBL] [Abstract][Full Text] [Related]
12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
14. [Principles in the treatment and rehabilitation of patients with tuberculosis]. Zhuk NA Probl Tuberk Bolezn Legk; 2005; (8):26-9. PubMed ID: 16209015 [TBL] [Abstract][Full Text] [Related]
15. [Roncoleukin in enhancing the efficiency of complex therapy for infiltrative pulmonary tuberculosis in adolescents]. Barmina NA; Burukhina LV; Shurygin AA; Archakova LI Probl Tuberk Bolezn Legk; 2009; (5):27-31. PubMed ID: 19565809 [TBL] [Abstract][Full Text] [Related]